nodes	percent_of_prediction	percent_of_DWPC	metapath
Degarelix—Ceruletide—CCKAR—type 2 diabetes mellitus	0.0239	1	CrCbGaD
Degarelix—GNRHR—Peptide GPCRs—MC4R—type 2 diabetes mellitus	0.00713	0.0354	CbGpPWpGaD
Degarelix—GNRHR—Peptide GPCRs—CCKAR—type 2 diabetes mellitus	0.00494	0.0246	CbGpPWpGaD
Degarelix—GNRHR—Peptide GPCRs—AGTR2—type 2 diabetes mellitus	0.00432	0.0215	CbGpPWpGaD
Degarelix—GNRHR—Peptide GPCRs—EDNRB—type 2 diabetes mellitus	0.00413	0.0206	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—GCGR—type 2 diabetes mellitus	0.00403	0.02	CbGpPWpGaD
Degarelix—GNRHR—Peptide GPCRs—EDNRA—type 2 diabetes mellitus	0.0039	0.0194	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—GRK5—type 2 diabetes mellitus	0.00371	0.0185	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GCGR—type 2 diabetes mellitus	0.00361	0.0179	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—type 2 diabetes mellitus	0.00332	0.0165	CbGpPWpGaD
Degarelix—GNRHR—GPCRs, Other—EDNRA—type 2 diabetes mellitus	0.00331	0.0165	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—MTNR1A—type 2 diabetes mellitus	0.00309	0.0154	CbGpPWpGaD
Degarelix—GNRHR—Peptide GPCRs—CCR5—type 2 diabetes mellitus	0.00252	0.0125	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—MTNR1A—type 2 diabetes mellitus	0.00236	0.0117	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—CCKAR—type 2 diabetes mellitus	0.00235	0.0117	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—MC4R—type 2 diabetes mellitus	0.00225	0.0112	CbGpPWpGaD
Degarelix—GNRHR—GPCRs, Other—CCR5—type 2 diabetes mellitus	0.00213	0.0106	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—type 2 diabetes mellitus	0.0021	0.0105	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—TRPC6—type 2 diabetes mellitus	0.00207	0.0103	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—GCGR—type 2 diabetes mellitus	0.00203	0.0101	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—EDNRB—type 2 diabetes mellitus	0.00197	0.00979	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—HTR2C—type 2 diabetes mellitus	0.00191	0.0095	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—GIPR—type 2 diabetes mellitus	0.00187	0.00931	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—EDNRA—type 2 diabetes mellitus	0.00186	0.00925	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—type 2 diabetes mellitus	0.00185	0.0092	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRB3—type 2 diabetes mellitus	0.00184	0.00915	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—GHRL—type 2 diabetes mellitus	0.00181	0.00901	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRB—type 2 diabetes mellitus	0.00176	0.00876	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—MC4R—type 2 diabetes mellitus	0.00171	0.00851	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—type 2 diabetes mellitus	0.00171	0.0085	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—type 2 diabetes mellitus	0.00166	0.00827	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—GCG—type 2 diabetes mellitus	0.00166	0.00824	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—GIP—type 2 diabetes mellitus	0.00165	0.00819	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—RASGRP1—type 2 diabetes mellitus	0.00163	0.00811	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—MTNR1B—type 2 diabetes mellitus	0.00163	0.00808	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—type 2 diabetes mellitus	0.00162	0.00806	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCKAR—type 2 diabetes mellitus	0.00156	0.00775	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 2 diabetes mellitus	0.00148	0.00737	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—type 2 diabetes mellitus	0.00146	0.00725	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—GNB3—type 2 diabetes mellitus	0.00143	0.0071	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—AVP—type 2 diabetes mellitus	0.00141	0.00701	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—ADRB3—type 2 diabetes mellitus	0.0014	0.00697	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGTR2—type 2 diabetes mellitus	0.00136	0.00677	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CRHR1—type 2 diabetes mellitus	0.00135	0.00673	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—EDN1—type 2 diabetes mellitus	0.00134	0.00667	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—MTNR1A—type 2 diabetes mellitus	0.00133	0.00662	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—EDNRB—type 2 diabetes mellitus	0.0013	0.00648	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GNB3—type 2 diabetes mellitus	0.00128	0.00635	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR2C—type 2 diabetes mellitus	0.00127	0.00629	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—type 2 diabetes mellitus	0.00126	0.00627	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—type 2 diabetes mellitus	0.00126	0.00627	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—MTNR1B—type 2 diabetes mellitus	0.00124	0.00615	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—EDNRA—type 2 diabetes mellitus	0.00123	0.00612	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—MTNR1A—type 2 diabetes mellitus	0.00121	0.00601	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—GLP1R—type 2 diabetes mellitus	0.00121	0.006	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRA2A—type 2 diabetes mellitus	0.00121	0.00599	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—GHRL—type 2 diabetes mellitus	0.0012	0.00597	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—type 2 diabetes mellitus	0.0012	0.00596	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CCKAR—type 2 diabetes mellitus	0.00119	0.0059	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—GCGR—type 2 diabetes mellitus	0.00115	0.00571	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—AGT—type 2 diabetes mellitus	0.00111	0.00553	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—IAPP—type 2 diabetes mellitus	0.00107	0.00531	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—GRK5—type 2 diabetes mellitus	0.00106	0.00526	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—GIPR—type 2 diabetes mellitus	0.00106	0.00526	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GCGR—type 2 diabetes mellitus	0.00104	0.00519	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—AGTR2—type 2 diabetes mellitus	0.00104	0.00516	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—type 2 diabetes mellitus	0.000995	0.00495	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—EDNRB—type 2 diabetes mellitus	0.000993	0.00494	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—ARAP1—type 2 diabetes mellitus	0.000988	0.00491	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—MC4R—type 2 diabetes mellitus	0.000967	0.00481	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—HTR2C—type 2 diabetes mellitus	0.000964	0.00479	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GIPR—type 2 diabetes mellitus	0.00096	0.00478	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GRK5—type 2 diabetes mellitus	0.00096	0.00478	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—EDNRA—type 2 diabetes mellitus	0.000938	0.00466	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—AVP—type 2 diabetes mellitus	0.000933	0.00464	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—GIP—type 2 diabetes mellitus	0.000931	0.00463	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—ADRA2A—type 2 diabetes mellitus	0.000918	0.00456	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—GHRL—type 2 diabetes mellitus	0.000914	0.00454	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—VPS26A—type 2 diabetes mellitus	0.000903	0.00449	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CALCA—type 2 diabetes mellitus	0.000903	0.00449	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—EDN1—type 2 diabetes mellitus	0.000888	0.00441	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—MC4R—type 2 diabetes mellitus	0.000878	0.00437	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GIP—type 2 diabetes mellitus	0.000846	0.0042	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—GCG—type 2 diabetes mellitus	0.000836	0.00416	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—PIK3R1—type 2 diabetes mellitus	0.000817	0.00406	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	0.000794	0.00395	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	0.000792	0.00394	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	0.000776	0.00386	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	0.000765	0.0038	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	0.000737	0.00366	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—type 2 diabetes mellitus	0.00073	0.00363	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—GNB3—type 2 diabetes mellitus	0.00072	0.00358	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	0.000719	0.00357	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.000714	0.00355	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—AVP—type 2 diabetes mellitus	0.000711	0.00353	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	0.000699	0.00348	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	0.000694	0.00345	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	0.000682	0.00339	CbGpPWpGaD
Degarelix—Rash—Glipizide—type 2 diabetes mellitus	0.000681	0.000878	CcSEcCtD
Degarelix—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.00068	0.000878	CcSEcCtD
Degarelix—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00068	0.000877	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.00068	0.000877	CcSEcCtD
Degarelix—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000679	0.000877	CcSEcCtD
Degarelix—Erythema—Losartan—type 2 diabetes mellitus	0.000679	0.000876	CcSEcCtD
Degarelix—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000677	0.000874	CcSEcCtD
Degarelix—Headache—Glipizide—type 2 diabetes mellitus	0.000676	0.000873	CcSEcCtD
Degarelix—GNRHR—GPCR ligand binding—EDN1—type 2 diabetes mellitus	0.000676	0.00336	CbGpPWpGaD
Degarelix—Palpitations—Metformin—type 2 diabetes mellitus	0.000676	0.000872	CcSEcCtD
Degarelix—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000675	0.000871	CcSEcCtD
Degarelix—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000672	0.000867	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	0.00067	0.00333	CbGpPWpGaD
Degarelix—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.00067	0.000864	CcSEcCtD
Degarelix—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000667	0.000861	CcSEcCtD
Degarelix—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000666	0.000859	CcSEcCtD
Degarelix—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000666	0.000859	CcSEcCtD
Degarelix—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000665	0.000858	CcSEcCtD
Degarelix—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000664	0.000857	CcSEcCtD
Degarelix—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000664	0.000857	CcSEcCtD
Degarelix—Hypertension—Metformin—type 2 diabetes mellitus	0.00066	0.000852	CcSEcCtD
Degarelix—Urticaria—Glyburide—type 2 diabetes mellitus	0.00066	0.000852	CcSEcCtD
Degarelix—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000659	0.00085	CcSEcCtD
Degarelix—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000658	0.000849	CcSEcCtD
Degarelix—Back pain—Losartan—type 2 diabetes mellitus	0.000657	0.000848	CcSEcCtD
Degarelix—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000657	0.000847	CcSEcCtD
Degarelix—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000655	0.000845	CcSEcCtD
Degarelix—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000653	0.000842	CcSEcCtD
Degarelix—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000652	0.000841	CcSEcCtD
Degarelix—Malaise—Irbesartan—type 2 diabetes mellitus	0.000651	0.00084	CcSEcCtD
Degarelix—Headache—Pioglitazone—type 2 diabetes mellitus	0.000648	0.000836	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000646	0.000834	CcSEcCtD
Degarelix—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000644	0.000831	CcSEcCtD
Degarelix—Discomfort—Metformin—type 2 diabetes mellitus	0.000643	0.00083	CcSEcCtD
Degarelix—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000643	0.00083	CcSEcCtD
Degarelix—Nausea—Glipizide—type 2 diabetes mellitus	0.000641	0.000827	CcSEcCtD
Degarelix—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00064	0.000826	CcSEcCtD
Degarelix—Hypotension—Valsartan—type 2 diabetes mellitus	0.00064	0.000826	CcSEcCtD
Degarelix—Vision blurred—Losartan—type 2 diabetes mellitus	0.00064	0.000826	CcSEcCtD
Degarelix—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000638	0.000824	CcSEcCtD
Degarelix—Constipation—Gliclazide—type 2 diabetes mellitus	0.000638	0.000823	CcSEcCtD
Degarelix—Pain—Gliclazide—type 2 diabetes mellitus	0.000638	0.000823	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	0.000635	0.00316	CbGpPWpGaD
Degarelix—Rash—Glimepiride—type 2 diabetes mellitus	0.000635	0.00082	CcSEcCtD
Degarelix—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000634	0.000819	CcSEcCtD
Degarelix—Rash—Sitagliptin—type 2 diabetes mellitus	0.000633	0.000817	CcSEcCtD
Degarelix—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000632	0.000816	CcSEcCtD
Degarelix—Headache—Glimepiride—type 2 diabetes mellitus	0.000631	0.000814	CcSEcCtD
Degarelix—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.00063	0.000813	CcSEcCtD
Degarelix—Headache—Sitagliptin—type 2 diabetes mellitus	0.000629	0.000812	CcSEcCtD
Degarelix—Anaemia—Losartan—type 2 diabetes mellitus	0.000628	0.00081	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000624	0.000806	CcSEcCtD
Degarelix—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000623	0.000804	CcSEcCtD
Degarelix—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000622	0.000802	CcSEcCtD
Degarelix—Insomnia—Valsartan—type 2 diabetes mellitus	0.00062	0.0008	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	0.000619	0.00308	CbGpPWpGaD
Degarelix—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000617	0.000796	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000616	0.00307	CbGpPWpGaD
Degarelix—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000615	0.000793	CcSEcCtD
Degarelix—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000614	0.000793	CcSEcCtD
Degarelix—Insomnia—Orlistat—type 2 diabetes mellitus	0.000612	0.00079	CcSEcCtD
Degarelix—Malaise—Losartan—type 2 diabetes mellitus	0.000612	0.00079	CcSEcCtD
Degarelix—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000612	0.00079	CcSEcCtD
Degarelix—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000612	0.00079	CcSEcCtD
Degarelix—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000611	0.000788	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.00061	0.000787	CcSEcCtD
Degarelix—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00061	0.000787	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	0.000609	0.00303	CbGpPWpGaD
Degarelix—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000607	0.000783	CcSEcCtD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	0.000607	0.00302	CbGpPWpGaD
Degarelix—Skin disorder—Metformin—type 2 diabetes mellitus	0.000606	0.000782	CcSEcCtD
Degarelix—GNRHR—GPCR ligand binding—CCR5—type 2 diabetes mellitus	0.000604	0.003	CbGpPWpGaD
Degarelix—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000604	0.00078	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	0.000604	0.003	CbGpPWpGaD
Degarelix—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000603	0.000778	CcSEcCtD
Degarelix—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000603	0.000778	CcSEcCtD
Degarelix—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000601	0.000775	CcSEcCtD
Degarelix—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000601	0.000775	CcSEcCtD
Degarelix—Palpitations—Losartan—type 2 diabetes mellitus	0.0006	0.000774	CcSEcCtD
Degarelix—Nausea—Glimepiride—type 2 diabetes mellitus	0.000598	0.000772	CcSEcCtD
Degarelix—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000598	0.000771	CcSEcCtD
Degarelix—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000596	0.00077	CcSEcCtD
Degarelix—Asthenia—Glyburide—type 2 diabetes mellitus	0.000596	0.000769	CcSEcCtD
Degarelix—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000596	0.000769	CcSEcCtD
Degarelix—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000593	0.000765	CcSEcCtD
Degarelix—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000592	0.000763	CcSEcCtD
Degarelix—Alopecia—Ramipril—type 2 diabetes mellitus	0.000591	0.000763	CcSEcCtD
Degarelix—Fatigue—Valsartan—type 2 diabetes mellitus	0.000591	0.000762	CcSEcCtD
Degarelix—GNRHR—GPCR ligand binding—C3—type 2 diabetes mellitus	0.000591	0.00294	CbGpPWpGaD
Degarelix—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00059	0.000761	CcSEcCtD
Degarelix—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00059	0.000761	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	0.000589	0.00293	CbGpPWpGaD
Degarelix—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000589	0.00076	CcSEcCtD
Degarelix—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000589	0.00076	CcSEcCtD
Degarelix—Pruritus—Glyburide—type 2 diabetes mellitus	0.000588	0.000758	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.000586	0.00291	CbGpPWpGaD
Degarelix—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000586	0.000756	CcSEcCtD
Degarelix—Constipation—Valsartan—type 2 diabetes mellitus	0.000586	0.000756	CcSEcCtD
Degarelix—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000585	0.000754	CcSEcCtD
Degarelix—Fatigue—Orlistat—type 2 diabetes mellitus	0.000584	0.000753	CcSEcCtD
Degarelix—Hypotension—Metformin—type 2 diabetes mellitus	0.000583	0.000752	CcSEcCtD
Degarelix—Erythema—Ramipril—type 2 diabetes mellitus	0.000582	0.000751	CcSEcCtD
Degarelix—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000582	0.000751	CcSEcCtD
Degarelix—Pain—Orlistat—type 2 diabetes mellitus	0.000579	0.000747	CcSEcCtD
Degarelix—Arthralgia—Losartan—type 2 diabetes mellitus	0.000578	0.000746	CcSEcCtD
Degarelix—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000578	0.000746	CcSEcCtD
Degarelix—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000578	0.000745	CcSEcCtD
Degarelix—Rash—Bromocriptine—type 2 diabetes mellitus	0.000573	0.000739	CcSEcCtD
Degarelix—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000572	0.000739	CcSEcCtD
Degarelix—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000572	0.000738	CcSEcCtD
Degarelix—Discomfort—Losartan—type 2 diabetes mellitus	0.000571	0.000737	CcSEcCtD
Degarelix—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000569	0.000735	CcSEcCtD
Degarelix—Headache—Bromocriptine—type 2 diabetes mellitus	0.000569	0.000735	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000569	0.000734	CcSEcCtD
Degarelix—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000568	0.000733	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000567	0.00282	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000567	0.00282	CbGpPWpGaD
Degarelix—Dry mouth—Losartan—type 2 diabetes mellitus	0.000565	0.00073	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000561	0.00279	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000561	0.00279	CbGpPWpGaD
Degarelix—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00056	0.000723	CcSEcCtD
Degarelix—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.00056	0.000722	CcSEcCtD
Degarelix—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000558	0.00072	CcSEcCtD
Degarelix—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000556	0.000718	CcSEcCtD
Degarelix—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000554	0.000715	CcSEcCtD
Degarelix—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000554	0.000715	CcSEcCtD
Degarelix—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00055	0.00071	CcSEcCtD
Degarelix—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00055	0.000709	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000548	0.00273	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.000545	0.00271	CbGpPWpGaD
Degarelix—Urticaria—Valsartan—type 2 diabetes mellitus	0.000544	0.000702	CcSEcCtD
Degarelix—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000544	0.000701	CcSEcCtD
Degarelix—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000542	0.0007	CcSEcCtD
Degarelix—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000542	0.000699	CcSEcCtD
Degarelix—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.00054	0.000697	CcSEcCtD
Degarelix—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00054	0.000696	CcSEcCtD
Degarelix—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000539	0.000695	CcSEcCtD
Degarelix—Fatigue—Metformin—type 2 diabetes mellitus	0.000538	0.000694	CcSEcCtD
Degarelix—Urticaria—Orlistat—type 2 diabetes mellitus	0.000538	0.000694	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000537	0.000692	CcSEcCtD
Degarelix—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000536	0.000691	CcSEcCtD
Degarelix—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000535	0.000691	CcSEcCtD
Degarelix—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000535	0.000691	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000535	0.00266	CbGpPWpGaD
Degarelix—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000535	0.000691	CcSEcCtD
Degarelix—Constipation—Metformin—type 2 diabetes mellitus	0.000534	0.000689	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000532	0.00265	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.00053	0.00264	CbGpPWpGaD
Degarelix—Vomiting—Glyburide—type 2 diabetes mellitus	0.000528	0.000682	CcSEcCtD
Degarelix—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000528	0.000681	CcSEcCtD
Degarelix—Malaise—Ramipril—type 2 diabetes mellitus	0.000525	0.000678	CcSEcCtD
Degarelix—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000525	0.000678	CcSEcCtD
Degarelix—Rash—Glyburide—type 2 diabetes mellitus	0.000524	0.000676	CcSEcCtD
Degarelix—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000523	0.000675	CcSEcCtD
Degarelix—Headache—Glyburide—type 2 diabetes mellitus	0.00052	0.000671	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000519	0.00258	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000519	0.00258	CbGpPWpGaD
Degarelix—Hypotension—Losartan—type 2 diabetes mellitus	0.000518	0.000668	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000516	0.00257	CbGpPWpGaD
Degarelix—Palpitations—Ramipril—type 2 diabetes mellitus	0.000515	0.000664	CcSEcCtD
Degarelix—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000514	0.000664	CcSEcCtD
Degarelix—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000512	0.000661	CcSEcCtD
Degarelix—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00051	0.000659	CcSEcCtD
Degarelix—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00051	0.000658	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.00051	0.00254	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.00051	0.00253	CbGpPWpGaD
Degarelix—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000508	0.000656	CcSEcCtD
Degarelix—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000508	0.000655	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000505	0.000652	CcSEcCtD
Degarelix—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000505	0.000652	CcSEcCtD
Degarelix—Pain—Irbesartan—type 2 diabetes mellitus	0.000504	0.00065	CcSEcCtD
Degarelix—Constipation—Irbesartan—type 2 diabetes mellitus	0.000504	0.00065	CcSEcCtD
Degarelix—Insomnia—Losartan—type 2 diabetes mellitus	0.000501	0.000647	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000499	0.00248	CbGpPWpGaD
Degarelix—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000499	0.000644	CcSEcCtD
Degarelix—Urticaria—Metformin—type 2 diabetes mellitus	0.000496	0.00064	CcSEcCtD
Degarelix—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000496	0.00064	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.000495	0.00246	CbGpPWpGaD
Degarelix—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000494	0.000638	CcSEcCtD
Degarelix—Nausea—Glyburide—type 2 diabetes mellitus	0.000493	0.000637	CcSEcCtD
Degarelix—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000493	0.000637	CcSEcCtD
Degarelix—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000493	0.000636	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000492	0.000635	CcSEcCtD
Degarelix—Asthenia—Valsartan—type 2 diabetes mellitus	0.000492	0.000634	CcSEcCtD
Degarelix—Discomfort—Ramipril—type 2 diabetes mellitus	0.00049	0.000632	CcSEcCtD
Degarelix—Asthenia—Orlistat—type 2 diabetes mellitus	0.000486	0.000627	CcSEcCtD
Degarelix—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000485	0.000626	CcSEcCtD
Degarelix—Pruritus—Valsartan—type 2 diabetes mellitus	0.000485	0.000626	CcSEcCtD
Degarelix—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000485	0.000626	CcSEcCtD
Degarelix—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000482	0.000622	CcSEcCtD
Degarelix—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000482	0.000621	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.000481	0.00239	CbGpPWpGaD
Degarelix—Pruritus—Orlistat—type 2 diabetes mellitus	0.000479	0.000618	CcSEcCtD
Degarelix—Fatigue—Losartan—type 2 diabetes mellitus	0.000478	0.000617	CcSEcCtD
Degarelix—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000475	0.000613	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000475	0.00236	CbGpPWpGaD
Degarelix—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000474	0.000612	CcSEcCtD
Degarelix—Pain—Losartan—type 2 diabetes mellitus	0.000474	0.000612	CcSEcCtD
Degarelix—Constipation—Losartan—type 2 diabetes mellitus	0.000474	0.000612	CcSEcCtD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	0.000474	0.00235	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—GCG—type 2 diabetes mellitus	0.000472	0.00235	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.000471	0.00234	CbGpPWpGaD
Degarelix—Rash—Gliclazide—type 2 diabetes mellitus	0.00047	0.000607	CcSEcCtD
Degarelix—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00047	0.000606	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.000469	0.00233	CbGpPWpGaD
Degarelix—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000469	0.000605	CcSEcCtD
Degarelix—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000468	0.000604	CcSEcCtD
Degarelix—Headache—Gliclazide—type 2 diabetes mellitus	0.000467	0.000603	CcSEcCtD
Degarelix—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000466	0.000601	CcSEcCtD
Degarelix—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000466	0.000601	CcSEcCtD
Degarelix—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000466	0.000601	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.000465	0.00231	CbGpPWpGaD
Degarelix—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000463	0.000598	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000463	0.0023	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000462	0.0023	CbGpPWpGaD
Degarelix—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000462	0.000596	CcSEcCtD
Degarelix—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000459	0.000593	CcSEcCtD
Degarelix—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000457	0.000589	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000454	0.00226	CbGpPWpGaD
Degarelix—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000453	0.000585	CcSEcCtD
Degarelix—Dizziness—Valsartan—type 2 diabetes mellitus	0.000453	0.000585	CcSEcCtD
Degarelix—Dizziness—Orlistat—type 2 diabetes mellitus	0.000448	0.000578	CcSEcCtD
Degarelix—Asthenia—Metformin—type 2 diabetes mellitus	0.000448	0.000578	CcSEcCtD
Degarelix—Hypotension—Ramipril—type 2 diabetes mellitus	0.000444	0.000573	CcSEcCtD
Degarelix—Nausea—Gliclazide—type 2 diabetes mellitus	0.000443	0.000572	CcSEcCtD
Degarelix—Pruritus—Metformin—type 2 diabetes mellitus	0.000442	0.00057	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000441	0.00219	CbGpPWpGaD
Degarelix—Urticaria—Losartan—type 2 diabetes mellitus	0.00044	0.000568	CcSEcCtD
Degarelix—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000438	0.000565	CcSEcCtD
Degarelix—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000438	0.000565	CcSEcCtD
Degarelix—Vomiting—Valsartan—type 2 diabetes mellitus	0.000436	0.000562	CcSEcCtD
Degarelix—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000434	0.00056	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000433	0.000559	CcSEcCtD
Degarelix—Rash—Valsartan—type 2 diabetes mellitus	0.000432	0.000558	CcSEcCtD
Degarelix—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000432	0.000557	CcSEcCtD
Degarelix—Vomiting—Orlistat—type 2 diabetes mellitus	0.000431	0.000556	CcSEcCtD
Degarelix—Insomnia—Ramipril—type 2 diabetes mellitus	0.00043	0.000555	CcSEcCtD
Degarelix—Headache—Valsartan—type 2 diabetes mellitus	0.000429	0.000554	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000429	0.00213	CbGpPWpGaD
Degarelix—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000427	0.000551	CcSEcCtD
Degarelix—Rash—Orlistat—type 2 diabetes mellitus	0.000427	0.000551	CcSEcCtD
Degarelix—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000427	0.00055	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000425	0.00211	CbGpPWpGaD
Degarelix—Headache—Orlistat—type 2 diabetes mellitus	0.000424	0.000547	CcSEcCtD
Degarelix—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000424	0.000547	CcSEcCtD
Degarelix—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000423	0.000545	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000422	0.0021	CbGpPWpGaD
Degarelix—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000417	0.000538	CcSEcCtD
Degarelix—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000413	0.000533	CcSEcCtD
Degarelix—Dizziness—Metformin—type 2 diabetes mellitus	0.000413	0.000533	CcSEcCtD
Degarelix—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.00041	0.000529	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.00041	0.00204	CbGpPWpGaD
Degarelix—Fatigue—Ramipril—type 2 diabetes mellitus	0.00041	0.000529	CcSEcCtD
Degarelix—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000408	0.000527	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000407	0.00202	CbGpPWpGaD
Degarelix—Nausea—Valsartan—type 2 diabetes mellitus	0.000407	0.000525	CcSEcCtD
Degarelix—Constipation—Ramipril—type 2 diabetes mellitus	0.000406	0.000524	CcSEcCtD
Degarelix—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000403	0.00052	CcSEcCtD
Degarelix—Nausea—Orlistat—type 2 diabetes mellitus	0.000402	0.000519	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000402	0.002	CbGpPWpGaD
Degarelix—Asthenia—Losartan—type 2 diabetes mellitus	0.000398	0.000513	CcSEcCtD
Degarelix—Vomiting—Metformin—type 2 diabetes mellitus	0.000397	0.000512	CcSEcCtD
Degarelix—Rash—Metformin—type 2 diabetes mellitus	0.000393	0.000508	CcSEcCtD
Degarelix—Dermatitis—Metformin—type 2 diabetes mellitus	0.000393	0.000507	CcSEcCtD
Degarelix—Pruritus—Losartan—type 2 diabetes mellitus	0.000392	0.000506	CcSEcCtD
Degarelix—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000392	0.000505	CcSEcCtD
Degarelix—Headache—Metformin—type 2 diabetes mellitus	0.000391	0.000504	CcSEcCtD
Degarelix—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000389	0.000503	CcSEcCtD
Degarelix—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000389	0.000501	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000382	0.0019	CbGpPWpGaD
Degarelix—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000379	0.000489	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000379	0.00188	CbGpPWpGaD
Degarelix—Urticaria—Ramipril—type 2 diabetes mellitus	0.000378	0.000487	CcSEcCtD
Degarelix—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000376	0.000485	CcSEcCtD
Degarelix—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000376	0.000485	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000375	0.00187	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000375	0.00187	CbGpPWpGaD
Degarelix—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000374	0.000483	CcSEcCtD
Degarelix—Rash—Irbesartan—type 2 diabetes mellitus	0.000371	0.000479	CcSEcCtD
Degarelix—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000371	0.000479	CcSEcCtD
Degarelix—Nausea—Metformin—type 2 diabetes mellitus	0.000371	0.000478	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.00037	0.00184	CbGpPWpGaD
Degarelix—Headache—Irbesartan—type 2 diabetes mellitus	0.000369	0.000476	CcSEcCtD
Degarelix—Dizziness—Losartan—type 2 diabetes mellitus	0.000366	0.000473	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000366	0.00182	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000366	0.00182	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000365	0.00181	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000365	0.00181	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	0.000364	0.00181	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000363	0.0018	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.00036	0.00179	CbGpPWpGaD
Degarelix—Vomiting—Losartan—type 2 diabetes mellitus	0.000352	0.000455	CcSEcCtD
Degarelix—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00035	0.000452	CcSEcCtD
Degarelix—Nausea—Irbesartan—type 2 diabetes mellitus	0.00035	0.000451	CcSEcCtD
Degarelix—Rash—Losartan—type 2 diabetes mellitus	0.000349	0.000451	CcSEcCtD
Degarelix—Dermatitis—Losartan—type 2 diabetes mellitus	0.000349	0.000451	CcSEcCtD
Degarelix—Headache—Losartan—type 2 diabetes mellitus	0.000347	0.000448	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000347	0.00172	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000342	0.0017	CbGpPWpGaD
Degarelix—Asthenia—Ramipril—type 2 diabetes mellitus	0.000341	0.00044	CcSEcCtD
Degarelix—Pruritus—Ramipril—type 2 diabetes mellitus	0.000336	0.000434	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000334	0.00166	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.00033	0.00164	CbGpPWpGaD
Degarelix—Nausea—Losartan—type 2 diabetes mellitus	0.000329	0.000425	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000326	0.00162	CbGpPWpGaD
Degarelix—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000325	0.00042	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000324	0.00161	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000322	0.0016	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000317	0.00158	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000316	0.00157	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000316	0.00157	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000314	0.00156	CbGpPWpGaD
Degarelix—Dizziness—Ramipril—type 2 diabetes mellitus	0.000314	0.000406	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.00031	0.00154	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000303	0.00151	CbGpPWpGaD
Degarelix—Vomiting—Ramipril—type 2 diabetes mellitus	0.000302	0.00039	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000301	0.0015	CbGpPWpGaD
Degarelix—Rash—Ramipril—type 2 diabetes mellitus	0.0003	0.000387	CcSEcCtD
Degarelix—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000299	0.000386	CcSEcCtD
Degarelix—Headache—Ramipril—type 2 diabetes mellitus	0.000298	0.000384	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000293	0.00146	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000292	0.00145	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000292	0.00145	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000288	0.00143	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000284	0.00141	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000283	0.00141	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000283	0.00141	CbGpPWpGaD
Degarelix—Nausea—Ramipril—type 2 diabetes mellitus	0.000282	0.000364	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000278	0.00138	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000277	0.00138	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000277	0.00138	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000274	0.00136	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000266	0.00132	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000258	0.00128	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000257	0.00128	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000253	0.00126	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000253	0.00126	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000249	0.00124	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000249	0.00124	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000237	0.00118	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000233	0.00116	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000233	0.00116	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.00022	0.0011	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000218	0.00109	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000215	0.00107	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000215	0.00107	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000215	0.00107	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000214	0.00106	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000211	0.00105	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000208	0.00104	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000207	0.00103	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000205	0.00102	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000199	0.000989	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000195	0.000968	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000187	0.000928	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000183	0.000911	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—C3—type 2 diabetes mellitus	0.000179	0.00089	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000171	0.000849	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.00017	0.000847	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—AGT—type 2 diabetes mellitus	0.00017	0.000846	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000167	0.000832	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000167	0.000829	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000167	0.000829	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000165	0.000819	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000157	0.000782	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000149	0.000739	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—INS—type 2 diabetes mellitus	0.000142	0.000708	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.00014	0.000697	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IGF1—type 2 diabetes mellitus	0.000138	0.000685	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—AKT2—type 2 diabetes mellitus	0.000138	0.000684	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—EGFR—type 2 diabetes mellitus	0.000137	0.000681	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	0.000131	0.00065	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NOS3—type 2 diabetes mellitus	0.000125	0.000621	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	0.000125	0.000621	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—RELA—type 2 diabetes mellitus	0.000118	0.000584	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	0.000107	0.000532	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CASP3—type 2 diabetes mellitus	0.000106	0.000527	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—IL6—type 2 diabetes mellitus	0.000105	0.000524	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—MMP9—type 2 diabetes mellitus	0.0001	0.000498	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.91e-05	0.000493	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.72e-05	0.000483	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—SRC—type 2 diabetes mellitus	9.24e-05	0.000459	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9e-05	0.000447	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.26e-05	0.000411	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.1e-05	0.000403	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IL6—type 2 diabetes mellitus	6.22e-05	0.000309	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.74e-05	0.000285	CbGpPWpGaD
